This white paper examines how lyophilization offers key advantages over liquid formulation, including extended stability of more than two years, and explores critical considerations for freeze-drying biologics.
Stability Advantages
Lyophilized products can remain stable for more than two years, easing storage and distribution.
Freeze-Drying Considerations
Cycle development, excipients and container closure all influence product quality.
Choosing the Right Presentation
Molecule characteristics, patient needs and supply chain constraints guide the choice between liquid and lyophilized forms.
About This White Paper
This white paper is published by IDT Biologika and curated by Biotechnology Media Insights, a trusted source for pharmaceutical and biotechnology research, technical guides and industry analysis.